Inpatient Financial Burden of Atopic Dermatitis in the United States
Research output: Contribution to journal › Journal article › peer-review
Standard
Inpatient Financial Burden of Atopic Dermatitis in the United States. / Narla, Shanthi; Hsu, Derek Y; Thyssen, Jacob P; Silverberg, Jonathan I.
In: The Journal of Investigative Dermatology, Vol. 137, No. 7, 2017, p. 1461-1467.Research output: Contribution to journal › Journal article › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Inpatient Financial Burden of Atopic Dermatitis in the United States
AU - Narla, Shanthi
AU - Hsu, Derek Y
AU - Thyssen, Jacob P
AU - Silverberg, Jonathan I
N1 - Copyright © 2017 The Authors. Published by Elsevier Inc. All rights reserved.
PY - 2017
Y1 - 2017
N2 - Little is known about the inpatient burden of atopic dermatitis (AD). We sought to determine the risk factors and financial burden of hospitalizations for AD in the United States. Data were analyzed from the 2002-2012 National Inpatient Sample, including a 20% representative sample of all hospitalizations in the United States. Hospitalization rates for AD or eczema were highest in the northeast during the winter and south during the summer. Geometric mean cost of care (95% confidence interval) was lower for a primary diagnosis of AD or eczema versus no AD or eczema in adults ($3,502 [$3,360-$3,651] vs. $6,849 [$6,775-$6,925]; P = 0.0004) and children ($2,716 [$2,542-$2,903] vs. $4,488 [$4,302-$4,682]; P = 0.0004). However, the high prevalence of hospitalization resulted in total inpatient costs of $8,288,083 per year for adults and $3,333,868 per year for children. In conclusion, there is a substantial inpatient financial burden of AD in the United States.
AB - Little is known about the inpatient burden of atopic dermatitis (AD). We sought to determine the risk factors and financial burden of hospitalizations for AD in the United States. Data were analyzed from the 2002-2012 National Inpatient Sample, including a 20% representative sample of all hospitalizations in the United States. Hospitalization rates for AD or eczema were highest in the northeast during the winter and south during the summer. Geometric mean cost of care (95% confidence interval) was lower for a primary diagnosis of AD or eczema versus no AD or eczema in adults ($3,502 [$3,360-$3,651] vs. $6,849 [$6,775-$6,925]; P = 0.0004) and children ($2,716 [$2,542-$2,903] vs. $4,488 [$4,302-$4,682]; P = 0.0004). However, the high prevalence of hospitalization resulted in total inpatient costs of $8,288,083 per year for adults and $3,333,868 per year for children. In conclusion, there is a substantial inpatient financial burden of AD in the United States.
KW - Adolescent
KW - Adult
KW - Child
KW - Cost of Illness
KW - Costs and Cost Analysis
KW - Dermatitis, Atopic/economics
KW - Female
KW - Health Care Costs
KW - Hospitalization/economics
KW - Humans
KW - Inpatients
KW - Male
KW - Prevalence
KW - Retrospective Studies
KW - United States/epidemiology
KW - Young Adult
U2 - 10.1016/j.jid.2017.02.975
DO - 10.1016/j.jid.2017.02.975
M3 - Journal article
C2 - 28259687
VL - 137
SP - 1461
EP - 1467
JO - Journal of Investigative Dermatology
JF - Journal of Investigative Dermatology
SN - 0022-202X
IS - 7
ER -
ID: 196884371